Business Update & Financial Outlook

Delivered on our key strategic priorities in Q2 2023 < Advanced the pipeline to meet patient unmet need Executed on strategic business development to enhance pipeline Achieved strong commercial and financial performance Created long-term value for patients and shareholders 00000 MERCK 5

View entire presentation